Načítá se...
Accumulated Pre-Switch Resistance to More Recently Introduced One-Pill-Once-a-Day Antiretroviral Regimens Impacts HIV-1 Virologic Outcome
BACKGROUND: One-pill-once-a-day regimens (OPODs) appeal to providers and patients. The impact of resistance to OPODs in routine clinical care is important yet unclear, particularly in treatment-experienced patients. OBJECTIVES: We hypothesized that resistance to any OPOD component impacts treatment...
Uloženo v:
| Vydáno v: | J Clin Virol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6054572/ https://ncbi.nlm.nih.gov/pubmed/29807234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2018.05.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|